WuXi PharmaTech Honored with 2006 Merck & Co., Inc. Outstanding Strategic Collaboration Award

WuXi PharmaTech Honored with 2006 Merck & Co., Inc. Outstanding Strategic Collaboration Award

March 19, 2007

    SHANGHAI, China, March 19 /Xinhua-PRNewswire/ -- WuXi
PharmaTech, China's leading provider of pharmaceutical
R&D outsourcing services announced today that it is a
recipient of the 2006 Merck  & Co., Inc.
"Outstanding Strategic Collaboration Award" for
its contribution to Merck's custom medicinal chemistry and
process research chemistry and commitment to develop and
grow capabilities to meet Merck's business needs.  The
award was presented to WuXi PharmaTech by Dr. John J. King,
Senior Vice President, Research Planning and Integration, at
Merck's New Jersey corporate headquarters on February 13,
2007.

    (Logo:
http://www.xprn.com.cn:9080/xprn/sa/200611271812.jpg )

    Merck's Supplier Recognition Forum is an annual event
that recognizes suppliers that provide outstanding services
to Merck.  This year's award, with the theme,
"Recognizing Supplier Contributions, Revealing
Strategic Business Opportunities", seeks to recognize
a select number of suppliers who have demonstrated unique
and exemplary performance in support of Merck.

    WuXi PharmaTech was one of the twelve companies
selected from thousands of suppliers to be honored at this
year's supplier recognition forum.  "I am honored to,
on behalf of WuXi PharmaTech's nearly 2,000 dedicated
employees, accept this award.  This award is symbolic of
our tireless commitment to quality and value,"
commented Dr. Ge Li, Chairman and CEO of WuXi PharmaTech. 
"We are greatly benefited from the relationship with
Merck & Co, Inc., and we have learned so much from
Merck to set very high internal standard and compete in a
very competitive industry," continued Dr. Li. 
 
    About WuXi PharmaTech Co., Ltd.

    Founded in 2001, Shanghai-based WuXi PharmaTech is
China's leading drug R&D service company.  As a
research-driven and customer-focused company, WuXi
PharmaTech offers global pharmaceutical and
biopharmaceutical companies a diverse, value-added, and
fully integrated portfolio of outsourcing services ranging
from discovery chemistry, and process chemistry to service
biology, bioanalytical chemistry, and large scale GMP
manufacturing.  WuXi PharmaTech assists its global partners
in shortening the cycle and lowering the cost of drug
discovery and development by providing cost-effective and
efficient outsourcing solutions that save our clients both
time and money.  Currently, our client list consists of 19
of the top 20 pharmaceutical, and 8 of the top 10
biopharmaceutical companies. For more information, please
visit http://www.pharmatechs.com .
 
    About Merck & Co., Inc.

    Merck & Co., Inc. is a global research-driven
pharmaceutical company dedicated to putting patients first.
 Established in 1891, Merck currently discovers, develops,
manufactures and markets vaccines and medicines to address
unmet medical needs.  The Company devotes extensive efforts
to increase access to medicines through far-reaching
programs that not only donate Merck medicines but help
deliver them to the people who need them.  Merck also
publishes unbiased health information as a not-for-profit
service.  For more information, visit http://www.merck.com
.


    For more information, please contact:

     Sherry Shao
     Tel:   [phone]
     Email: [e-mail]